BOARD MEMBERS
E. David Crawford, M.D.
Chairman
Chairman of PCEC since 1989. Researcher-physician E. David Crawford, MD, has devoted his career in medicine to educating the public about men’s health issues and finding effective techniques and procedures to address prostate cancer. Dr. Crawford is currently a Professor of Urology at the University of California, San Diego, an emeritus distinguished endowed Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado.
Daniel P. Petrylak, M.D.
Treasurer
Daniel P. Petrylak, MD, recently named Leader of Prostate Medical Oncology at Yale Cancer Center in New Haven, CT. Dr. Petrylak, an internationally known medical oncologist, to lead the genitourinary cancers medical oncology team at Smilow Cancer Hospital and as director of the prostate cancer research group and co-director of the Signal Transduction Research Program. Dr. Petrylak joins Yale from NewYork-Presbyterian Hospital/Columbia University Medical Center.
Tracy McGowan, M.D.
Board Member
Dr. Tracy McGowan recently retired after nearly 20 years at Johnson & Johnson (J&J), where she most recently served as the Therapeutic Area Head for Prostate Cancer. During her tenure, she led cross-functional teams responsible for the successful launch of nine new oncology therapies—three for prostate cancer and one for bladder cancer. Her leadership was instrumental in designing pivotal clinical trials, fostering collaborations with leading scientific and advocacy organizations, and building high-performing teams that earned widespread recognition through publications and presentations.
